There are currently 8 clinical trials in Cypress, California looking for participants to engage in research studies. Trials are conducted at various facilities, including WCCT Global, West Coast Clinical Trials, WCCT Global, Inc and WCCT Global, LLC. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Multiple Ascending Dose Trial of Emraclidine in Elderly Participants
Recruiting
The primary purpose of the study is to evaluate the safety and tolerability of multiple ascending doses of emraclidine administered orally to elderly participants.
Gender:
All
Ages:
Between 65 years and 85 years
Trial Updated:
03/12/2024
Locations: Cypress, California, Cypress, California
Conditions: Healthy Participants
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Recruiting
The aim of this study is to assess the safety and tolerability of EFX compared to placebo in subjects with non-invasively diagnosed NASH/MASH and NAFLD/MASLD.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
02/28/2024
Locations: Akero Clinical Study Site, Cypress, California
Conditions: NASH/MASH, NAFLD/MASLD
Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir
Recruiting
This study will assess comparative bioavailability and effect of food on a prototype fixed-dose combination (FDC) of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in healthy subjects
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
01/11/2024
Locations: Atea Study Site, Cypress, California
Conditions: Healthy Volunteer Study
A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants
Recruiting
In this study, a known investigational medicine called 'semaglutide' will be tested in 2 different tablet versions. In addition to semaglutide, the tablet versions contain different helping agents in different amounts. Both tablet versions have a helping agent called SNAC. The main aim of this study is to investigate semaglutide of 4 different doses in a new tablet by determining the amount of semaglutide in the blood and compare the concentration in the blood for the new tablet with the tablet... Read More
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
10/31/2023
Locations: Novo Nordisk Investigational Site, Cypress, California
Conditions: Healthy Participants
Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects
Recruiting
The goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics (PK; drug metabolism) of DF-003 after oral administration of single and multiple ascending doses in healthy subjects. The choice of using healthy subjects is standard in establishing the preliminary safety and PK profile of a drug. DF-003 is a potent small molecule inhibitor of alpha-kinase 1 (ALPK1), which plays an important role in immunity and inflammation. DF-003 can inhibit the immune inflammatory... Read More
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
09/12/2023
Locations: Altasciences Clinical Los Angeles, Inc, Cypress, California
Conditions: Healthy, Safety and Tolerability
A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood
Recruiting
The study is testing a new study medicine to treat people with high levels of fat in the blood. The main aim of the study is to see if the new study medicine is safe and how it works in the body. Participants will either get NNC0491-6075 (the new study medicine) or placebo (a "dummy medicine" without active ingredients). Which treatment participants get is decided by chance. NNC0491-6075 is a new medicine which cannot be prescribed by doctors. The study has 3 parts (Part A, Part B and Part C). I... Read More
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
08/08/2023
Locations: Novo Nordisk Investigational Site, Cypress, California
Conditions: Healthy Volunteers, Dyslipidaemia
Study of OsrhAAT or Placebo in Healthy Volunteers
Recruiting
A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Single Ascending Doses of OsrhAAT in Healthy Volunteers
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
12/08/2022
Locations: Altasciences, Cypress, California
Conditions: Emphysema Secondary to Congenital AATD
A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Recruiting
This Phase 1 study is planned to establish the clinical safety and pharmacokinetics profile of multiple dose of LT3001 drug product and to investigate drug interactions of LT3001 with potential concomitant medications in healthy subjects.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/17/2021
Locations: Lumosa Phase 1 Unit, Cypress, California
Conditions: Acute Ischemic Stroke